Status:
UNKNOWN
Ovarium Cancer Detection by TEP's and ctDNA
Lead Sponsor:
Gynaecologisch Oncologisch Centrum Zuid
Collaborating Sponsors:
Leiden University Medical Center
The Netherlands Cancer Institute
Conditions:
Ovarian Neoplasms
Eligibility:
FEMALE
18-90 years
Brief Summary
Rationale: Cancer is primarily diagnosed by clinical presentation, imaging and pathological analysis of tissue biopsies, increasingly supported by molecular diagnostics tests. However, late diagnosis ...
Detailed Description
Cancer is primarily diagnosed by clinical presentation, radiology, biochemical tests and pathological analysis of tumor tissue, increasingly supported by molecular diagnostic tests. Molecular profilin...
Eligibility Criteria
Inclusion
- Suspicion of ovarian cancer.
Exclusion
- Previous intraabdominal malignancies in the history
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04022863
Start Date
July 1 2019
End Date
December 1 2023
Last Update
July 17 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Catharina hospital
Eindhoven, North Brabant, Netherlands, 5623EJ
2
Netherlands Cancer Institute
Amsterdam, North Holland, Netherlands, 1066 CX
3
Leiden University Medical Center
Leiden, North Holland, Netherlands, 2333 ZA